CA Patent

CA3182412A1 — Advantageous benzothiophene compositions for mental disorders or enhancement

Assigned to Tactogen Inc · Expires 2022-01-13 · 4y expired

What this patent protects

Pharmaceutically active benzothiophene compounds and their pharmaceutically acceptable salts and salt mixtures and pharmaceutically acceptable compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy, and generally for modul…

USPTO Abstract

Pharmaceutically active benzothiophene compounds and their pharmaceutically acceptable salts and salt mixtures and pharmaceutically acceptable compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy, and generally for modulating central nervous system activity.

Drugs covered by this patent

Patent Metadata

Patent number
CA3182412A1
Jurisdiction
CA
Classification
—
Expires
2022-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Tactogen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.